1 month What is Zacks Research’s Estimate for TBPH Q4 Earnings?MarketBeat
Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) – Equities research analysts at Zacks Research upped their Q4 2025 earnings estimates for shares of Theravance Biopharma in a research note issued to investors on Monday, October 21st. Zacks Res…
Earnings · Nasdaq 100 · Science
X